Do Patients Need a Hub or a Better Patient Support Model?
Disruption in the patient services landscape is prompting biopharmaceutical manufacturers to reassess their patient support strategies. While maintaining continuity of care and minimizing operational disruption remain immediate priorities, this period of change presents a broader opportunity to rethink how patient support is designed and delivered.
Traditional hub models may no longer meet the evolving needs of patients, providers and brands. As specialty therapies expand into primary care, telehealth and direct-to-patient channels, manufacturers must consider whether centralized services, flexible field teams, digital capabilities or a combination of approaches can deliver a more connected and effective support experience.
In this article, Syneos Health experts explore how manufacturers can move beyond simply replacing hub vendors to build adaptable, data-informed patient support models. Discover how aligning services with patient journeys, integrating emerging technologies and prioritizing compliant data sharing can help reduce friction and support evolving brand needs.
What you will learn:
- How to maintain patient and provider continuity during hub transitions while identifying opportunities to improve existing workflows
- When a traditional hub is necessary and how modular support models can better align with evolving patient and provider needs
- How artificial intelligence (AI), field reimbursement teams and digital channels are reshaping patient support delivery
- Why connected data, compliant intelligence, and cross-functional coordination are essential to more responsive patient support
- How to develop a flexible patient support strategy that adapts to changing market conditions and brand lifecycle needs
